Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Change in Inventory: 2009-2015

Historic Change in Inventory for Lineage Cell Therapeutics (LCTX) over the last 7 years, with Dec 2015 value amounting to $75,000.

  • Lineage Cell Therapeutics' Change in Inventory rose 575.00% to $81,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $75,000, marking a year-over-year decrease of 13.79%. This contributed to the annual value of $75,000 for FY2015, which is 13.79% down from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Change in Inventory of $75,000 as of FY2015, which was down 13.79% from $87,000 recorded in FY2014.
  • Lineage Cell Therapeutics' Change in Inventory's 5-year high stood at $123,000 during FY2013, with a 5-year trough of -$31,094 in FY2011.
  • Its 3-year average for Change in Inventory is $95,000, with a median of $87,000 in 2014.
  • As far as peak fluctuations go, Lineage Cell Therapeutics' Change in Inventory plummeted by 380.28% in 2011, and later surged by 2,870.30% in 2013.
  • Over the past 5 years, Lineage Cell Therapeutics' Change in Inventory (Yearly) stood at -$31,094 in 2011, then soared by 113.32% to $4,141 in 2012, then spiked by 2,870.30% to $123,000 in 2013, then fell by 29.27% to $87,000 in 2014, then dropped by 13.79% to $75,000 in 2015.